http://www.fda.gov/cder/orange/appendix_a.txt ACTHAR GEL, CORTICOTROPIN H.R.-50, HYDROCHLOROTHIAZIDE HABITROL, NICOTINE (OTC) HALCION, TRIAZOLAM HALDOL SOLUTAB, HALOPERIDOL HALDOL, HALOPERIDOL HALDOL, HALOPERIDOL DECANOATE HALDOL, HALOPERIDOL LACTATE HALDRONE, PARAMETHASONE ACETATE HALFAN, HALOFANTRINE HYDROCHLORIDE HALOG, HALCINONIDE HALOG-E, HALCINONIDE HALOPERIDOL DECANOATE, HALOPERIDOL DECANOATE HALOPERIDOL INTENSOL,...
Drug Approval Package: Hepatolite 18467-S13 & S14 FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Drug Review Package Heptolite, Kit for the Preparation of Technetium Tc 99m Disofenin Company:- The Du Pont Merck Pharmaceutical Company Application No.:- 18467/ S-13 & S-14 Approval Date:-12/29/93 Approval Letter(s) - Printed Labeling - Medical Review(s) -...
Prescription and OTC Drug Product List 3/1999 Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 3: March 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CAPSULE; ORAL CHLORIDE; SODIUM PHOSPHATE...
1996 and Older - New Drug Application (NDA) New Drug Approval Packages These drug approval packages, sorted by product trade name, are supplied by the CDER Freedom of Electronic Information OfficeKit for the Preparation of Technetium Tc 99m Disofenin Merck...
chrmscat.p65 page 1
author: cxm9300
LIST OF APPROVED DRUGS FOR WHICH ADDITIONAL PEDIATRIC INFORMATION Medical Imaging And Radiopharmaceutical Drug Products Technetium Tc -99m Apcitide Scintigraphic imaging of acute venous thrombosis in the lower extremities in patients who have signs and symptoms of acute venous thrombosisTechnetium Tc -99m Bicisate Adjunct to conventional CT or MRI imaging in...
may20lst.PDF Iofetamine I- 123 Radioactive diagnostic- nonlacunar stroke Yes Yes Yes Yes Iopromide Aortography and visceral angiography coronary arteriography/ left ventriculography Yes Yes No No Iotrolan For contrast enhancement for lumbar, thoracic, cervical and total columnar myelography of spinal and subarachnoid spaces Yes Yes Yes Yes Ioversol Radiopaque diagnostic (cerebral angiography and...
author: Unknown
may20lst.PDF page 10
author: Unknown
http://www.freseniushc.com/product/April_1_2001_Update.pdf April 1 2001 Update Addendum A. Update of Calendar Year 2001 Hospital Outpatient Payment Rates and Coinsurance Amounts Effective April 1, 2001 National Minimum Status Relative Payment Unadjusted Unadjusted APC Group Title Indicator Weight Rate Coinsurance Coinsurance 0001 Photochemotherapy ...
http://www.freseniushc.com/product/April_1_2001_Update.pdf page 8 April 1 2001 Update 1024 Quinupristin 150 mg/ dalfopriston 350 J $102.05 $13.67 $13.67 1045 I- 131 MIBG (ioben- sulfate) O. 5mCi G $1,140.00 $139.08 $139.08 1059 Carticel, auto cult- chndr cyte G $14,250.00 $2,010.00 $2,010.00 1079 CO 57/ 58 0.5 mCi G $264.10 $32.22 $32.22 1084 Denileukin diftitox, ...
Palatin Technologies - The Leader in Melanocortin-based Therapeutics To address this issue, Tyco International today brought together a broad panel of medical and economic experts to outline the problem and describe how a breakthrough imaging agent, NeutroSpec(TM) [Technetium (99m Tc) fanolesomab], can help reduce the human pain and economic cost of misdiagnosed appendicitis.technetium -labeled anti-CD...
Palatin Technologies - The Leader in Melanocortin-based Therapeutics (Amex: PTN - News) today announced that they have extended their marketing agreement for Palatin's infection imaging agent, NeutroSpec(TM) (Technetium Tc -99m fanolesomab), to include exclusive marketing and distribution rights in Europe.
Palatin Technologies - The Leader in Melanocortin-based Therapeutics Rapid diagnosis of pedal osteomyelitis in diabetics with a Technetium -99m -labeled monoclonal antigranulocyte antibody.Tc -99m anti-CD 15 neutrophil monoclonal antibody (NeutroSpec®) scan for diagnosis of equivocal appendicitis: Clinical evaluation of safety, efficacy and patient management.99m Tc -labeled IgM...
PII: S0969-8051(01)00218-9 page 5
PII: S0969-8051(01)00218-9 page 4
doi:10.1016/S0969-8051(03)00028-3 page 7
doi:10.1016/S0969-8051(03)00028-3 page 2
http://www.neoprobe.com/UCSD/ASOwallace2003.pdf page 8
neo2000 Manual DOC0755 Rev D ° Radionuclide is automatically set to Technetium 99m, and this indicator lights up.Technetium 99m. 99m Tc isotope selected.
author: Shelley Holloway
DRAXIS Health Inc. It is formulated as an easy-to-use lyophilized kit for reconstitution with Technetium -99m radioisotope, and is currently in the latter stages of two Phase III clinical trials in Canada and the United States.kit for reconstitution with Technetium -99m and is under development and...
DRAXIS Health Inc. INFECTON® is the proprietary combination of the widely used antibiotic, ciprofloxacin, with Technetium ( 99m Tc), the most commonly used radioisotope in nuclear medical imaging.kit for the preparation of 99m Tc -ciprofloxacin is a diagnostic radiopharmaceutical that has the potential to selectively distinguish infection...
DRAXIS Health Inc. News Releases - - February 16, 2005 DRAXIS Diagnostic Radiopharmaceutical Approved in First European Country Approval in Netherlands for MAA diagnostic kit for lung imaging paves way for additional products and countries across Europe MISSISSAUGA, Ontario – February 16, 2005 – DRAXIS Health Inc.
Cytogen: ProstaScint Q&A for Doctors site map contact us home SEARCH- ABOUT CYTOGEN PRODUCTS HEALT H CARE PROFESSIONAL Quadramet Information ProstaScint Information FAQs Clinical Pharmacology PIE™ Site Directory Reimbursement Information Prescribing Information Information Re quest Recent Publications Other Resources PATIENT RESOURCE CENTER PIPELINE INVESTOR RELATIONS NEWSROOM CAREERS LICENSING OPPORTUNITIES...
DRAXIS Health Inc. News Releases - - January 9, 2003 DRAXIS to Initiate Phase I Clinical Testing of INFECTON Novel radiopharmaceutical designed for diagnostic imaging of infection MISSISSAUGA, Ontario - Januray 9, 2003 - DRAXIS Health Inc.
DRAXIS Health Inc. INFECTON combines the widely used antibiotic, ciprofloxacin, with Technetium ( 99m Tc), the most commonly used radioisotope in nuclear medical imaging.Kit for the preparation of 99m Tc -ciprofloxacin is a diagnostic radiopharmaceutical that has the potential to selectively distinguish infection from inflammation by binding...
